RecruitingNot Applicable

Control Cohort CTRL COH

France350 participantsStarted 2023-08-08

Plain-language summary

Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient with consent * patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis. Exclusion Criteria: * refusal consent * patient with neurological disorder compatible with paraneoplastic neurological syndrome or auto-immune encephalitis * patient under guardianship

What they're measuring

Samples (blood dry and EDTA tube and optional cerebro-spinal-fluid)

Timeframe: 15 minutes

Trial details

NCT IDNCT05370079

SponsorHospices Civils de Lyon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-08-08

Contact for this trial

Jerome Honnorat, Pr

(33) 4 72 35 78 06 jerome.honnorat@chu-lyon.fr

View on ClinicalTrials.gov More Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis trials